Skip to main content
OpenTrials

Clinical trial condition

Communicable Diseases

Explore clinical trials studying Communicable Diseases. Study availability and eligibility vary by location and protocol.

9,143 public trials 552 recruiting studies
Refine in advanced search Browse all conditions

Communicable Diseases trial results

Active, Not Recruiting

Study of Bepirovirsen in Participants Living With Human Immunodeficiency Virus and Chronic Hepatitis B Virus Infection (B-Focus)

NCT06497504

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +20 more
Locations
  • GSK Investigational Site Bakersfield, California, United States
  • GSK Investigational Site San Francisco, California, United States
  • GSK Investigational Site Orlando, Florida, United States
  • GSK Investigational Site West Palm Beach, Florida, United States
View all 51 locations
View Trial Details
Active, Not Recruiting

Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine From Current Antiretroviral Regimen in Virologically Suppressed HIV-1-infected Adults

NCT02951052

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Bakersfield, California, United States
  • GSK Investigational Site Long Beach, California, United States
View all 113 locations
View Trial Details
Active, Not Recruiting

A Study of Sequential Therapy With Daplusiran/Tomligisiran (DAP/TOM) Followed by Bepirovirsen in Participants Living With Chronic Hepatitis B (CHB)

NCT06537414

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B Virus Infection, +15 more
Locations
  • GSK Investigational Site San Francisco, California, United States
  • GSK Investigational Site San Jose, California, United States
  • GSK Investigational Site Minneapolis, Minnesota, United States
  • GSK Investigational Site New York, United States
View all 80 locations
View Trial Details
Active, Not Recruiting

Risk of Morbidity, Mortality and Long-term Monitoring of Antiretroviral Treatment in People Living With HIV

NCT03296202

Conditions
Antiretroviral Agents, Blood-Borne Infections, Communicable Diseases, +12 more
Locations
  • service de médecine interne - CH d'Agen Agen, France
  • Médecine interne - CH d'Angoulême Angoulême, France
  • service de maladies infectieuses - CH de la Côte Basque Bayonne, France
  • service de médecine inter et maladies infectieuses - Hopital Saint André Bordeaux, France
View all 19 locations
View Trial Details
Active, Not Recruiting

Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S03)

NCT06611540

Conditions
Cervical Carcinoma, Communicable Diseases, DNA Virus Infections, +23 more
Locations
  • Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
  • UofL Health Medical Center Northeast Louisville, Kentucky, United States
  • University of Michigan Rogel Cancer Center Ann Arbor, Michigan, United States
  • Minneapolis VA Medical Center Minneapolis, Minnesota, United States
View Trial Details
Active, Not Recruiting

Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S02)

NCT06611553

Conditions
Cervical Carcinoma, Communicable Diseases, DNA Virus Infections, +23 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Yale University New Haven, Connecticut, United States
  • University of Miami Miller School of Medicine-Sylvester Cancer Center Miami, Florida, United States
  • Louisiana State University Health Science Center New Orleans, Louisiana, United States
View all 14 locations
View Trial Details
Active, Not Recruiting

A Study to Investigate the Use of VH3810109 With or Without Fostemsavir (FTR) to Reduce the Size and Activity of the Viral Reservoir in People Living With HIV

NCT07053384

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +13 more
Locations
  • GSK Investigational Site Bakersfield, California, United States
  • GSK Investigational Site San Diego, California, United States
  • GSK Investigational Site Ft. Pierce, Florida, United States
  • GSK Investigational Site Orlando, Florida, United States
View all 41 locations
View Trial Details

Related conditions